CJEU: single clinical trial not sufficient for genuine use

European Union

In Viridis Pharmaceutical Ltd v EUIPO, the Court of Justice of the European Union has confirmed that there was no genuine use of Viridis’ trademark BOSWELAN on a pharmaceutical product nor proper reasons for non-use.

Unlock unlimited access to all WTR content